EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Clinical validation of AI‐assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance

Najmeh Arjmandi, Ahmed Reza Sebzari, Fatemeh Molaei, Saeid Rezaei, Maryam Rezaie-Yazdi, Malihe Rezaie-Yazdi

Journal of Applied Clinical Medical Physics · 2026-01 · 27 (1)

DOI: 10.1002/acm2.70425 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 19.12.2025. Verfasst von Najmeh Arjmandi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, School of Paramedical Sciences, Gerash University of Medical Sciences, Gerash, Iran. Hauptthemen laut MEDLINE: Radiotherapy Planning, Computer-Assisted, Prostatic Neoplasms, Organs at Risk, Quality Assurance, Health Care. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluated the impact of a commercial AI‐assisted contouring tool on intra‐ and inter‐observer variability in prostate radiation therapy and assessed the dosimetric consequences of geometric contour differences.

Methods

Two experienced radiation oncologists independently delineated clinical target volume (CTV) and organs at risk (OARs) for prostate cancer patients. Manual contours (C man ) and AI‐generated contours (C AI ) were compared with adjusted AI contours (C AI,adj ). A consensus reference (C ref ) served as the benchmark. To evaluate clinical impact, treatment plans were recalculated and replanned on each contour set under identical beam geometries to assess dose–volume histogram (DVH) parameters.

Results

AI‐assisted contouring significantly improved both intra‐ and inter‐observer agreement. Inter‐observer analysis revealed that the Dice similarity coefficient (DSCs) for CTV increased from 0.78 (± 0.11) for C man to 0.89 (± 0.09) for C AI, adj . Similarly, intra‐observer analysis revealed that both oncologists showed significantly higher DSCs for C AI, adj compared to C man . A thorough geometric comparison to the C ref revealed that while adjustments to C AI improved accuracy, they generally did not surpass C man for CTV and rectum. Dosimetric analyses demonstrated that, under fixed plan geometry, both C man and C AI,adj contours yielded lower planning target volume (PTV) D95% values compared with C ref , whereas after replanning, all plans met institutional criteria with no clinically significant differences among contour sets.

Conclusion

AI‐assisted contouring in prostate radiotherapy reduced intra‐ and inter‐observer variability and improved contouring consistency. However, C AI, adj did not consistently surpass C man , especially for the CTV and rectum, where automation bias or selective clinical acceptance may have influenced edits. Fixed‐plan recalculations revealed dose differences from minor geometric deviations. These findings underscore the importance of structured quality assurance (QA) and human oversight to mitigate automation bias while leveraging AI's efficiency. The single‐institution design with two oncologists and one AI software limits generalizability, underscoring the need for multi‐observer validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy Planning, Computer-AssistedProstatic NeoplasmsOrgans at RiskQuality Assurance, Health CareArtificial IntelligenceHumansMaleRadiotherapy DosageRadiotherapy, Intensity-ModulatedAutomation

Stichwörter der Autor:innen

Automation biasAuto‐contouringDeep learningInter‐observer variabilityIntra‐observer variabilityQuality assuranceRadiotherapy

Autor:innen und Institutionen

  • Department of Radiology, School of Paramedical Sciences, Gerash University of Medical Sciences, Gerash, Iran.
  • Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
  • Department of Radiation Oncology, Iran Mehr Hospital, Birjand University of Medical Sciences, Birjand, Iran.
  • Radiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Physics Unit, Department of Radiation Oncology, Iran Mehr Hospital, Birjand University of Medical Sciences, Birjand, Iran.

Zitieren

APA

Arjmandi, N., Sebzari, A. R., Molaei, F., Rezaei, S., Rezaie-Yazdi, M., & Rezaie-Yazdi, M. (2026). Clinical validation of AI‐assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance. Journal of Applied Clinical Medical Physics, 27(1). https://doi.org/10.1002/acm2.70425

Vancouver

Arjmandi N, Sebzari AR, Molaei F, Rezaei S, Rezaie-Yazdi M, Rezaie-Yazdi M. Clinical validation of AI‐assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance. Journal of Applied Clinical Medical Physics. 2026;27(1). doi:10.1002/acm2.70425

BibTeX
@article{Arjmandi2026,
  author = {Arjmandi, Najmeh and Sebzari, Ahmed Reza and Molaei, Fatemeh and Rezaei, Saeid and Rezaie-Yazdi, Maryam and Rezaie-Yazdi, Malihe},
  title = {Clinical validation of AI‐assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  volume = {27},
  number = {1},
  doi = {10.1002/acm2.70425}
}
Kostenlos starten →